Abraxane and Protein - urine - a phase IV clinical study of FDA data

Summary:

Protein - urine is reported as a side effect among people who take Abraxane (paclitaxel), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Avastin, and have Lung cancer - non-small cell.

The phase IV clinical study analyzes which people have Protein - urine when taking Abraxane. It is created by eHealthMe based on reports of 19,123 people who have side effects when taking Abraxane from the FDA, and is updated regularly.

What is Abraxane?

Abraxane has active ingredients of paclitaxel. It is often used in breast cancer metastatic. eHealthMe is studying from 19,196 Abraxane users. Check the latest studies of Abraxane.

What is Protein - urine?

Protein - urine is found to be associated with 1,568 drugs and 2,011 conditions by eHealthMe. Check the latest studies of Protein - urine.

On Jul, 19, 2026

19,123 people reported to have side effects when taking Abraxane.
Among them, 37 people (0.19%) have Protein - urine.

Among these 37 people:

How long have people been on Abraxane when they have Protein - urine? *

What is the gender of people who have Protein - urine when taking Abraxane? *

female: 83.33 %
male: 16.67 %

What is the age of people who have Protein - urine when taking Abraxane? *

What are other drugs people take besides Abraxane? *

What are other side effects people have besides Protein - urine? *

Fatigue (feeling of tiredness): 15 people, 40.54%
High Blood Pressure: 12 people, 32.43%
Diarrhea: 11 people, 29.73%
Nausea (feeling of having an urge to vomit): 10 people, 27.03%
Rashes (redness): 10 people, 27.03%
Peripheral Sensory Neuropathy (damage to one or more of your peripheral nerves): 10 people, 27.03%
Neuropathy Peripheral (surface nerve damage): 10 people, 27.03%
Thrombocytopenia (decrease of platelets in blood): 9 people, 24.32%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 9 people, 24.32%
Hair Loss: 8 people, 21.62%

What are the existing conditions these people have? *

Lung Cancer - Non-Small Cell (lung cancer): 5 people, 13.51%
Breast Cancer Female: 4 people, 10.81%
Pancreatic Carcinoma (pancreatic cancer): 2 people, 5.41%
Gastric Cancer (stomach cancer): 2 people, 5.41%
Transitional Cell Carcinoma (cancer tumour inner most layer of urinary system): 1 person, 2.70%
Stress And Anxiety: 1 person, 2.70%
Ovarian Cancer (cancer of ovary): 1 person, 2.70%
Non-Small Cell Lung Cancer Recurrent (type of epithelial lung cancer reoccurrence): 1 person, 2.70%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 1 person, 2.70%
Metastatic Gastric Cancer (cancer types can spread to the stomach from other place): 1 person, 2.70%

* Approximation only. Some reports may have incomplete information.

Do you take Abraxane and have Protein - urine?

- Check whether Protein - urine is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Abraxane:

Abraxane (19,196 reports)

Protein - urine treatments and more:

Protein - urine (24,757 reports)

Browse all side effects of Abraxane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Protein - urine:

Protein - urine (1,568 drugs)

Browse all the conditions that are associated with Protein - urine:

Protein - urine (2,011 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on paclitaxel (the active ingredients of Abraxane) and Abraxane (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.